FDA Adverse Event Injury Summary report: N

OT ULTRAMINI METER

MDR report key: 3865068 · Received June 11, 2014

Report

Report Number
2939301-2014-14071
Event Type
Injury
Date Received
June 11, 2014
Report Date
June 6, 2014
Manufacturer
LIFESCAN EUROPE, A DIVISION OF CILAG GMBH INTL
Product Code
NBW
PMA / PMN Number
K061118
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
FL, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

FOLLOW-UP # 1 ¿ (07/08/2014). THE PATIENT¿S METER HAS BEEN RETURNED ON 6/20/2014 AND EVALUATED BY LIFESCAN PRODUCT ANALYSIS ON 6/25/2014 WITH THE FOLLOWING FINDINGS:THE METER PASSED ALL TESTING WITH NO FAULTS FOUND. THE REPORTED ISSUE COULD NOT BE REPRODUCED. IF LIFESCAN OBTAINS ADDITIONAL INFORMATION REGARDING THIS COMPLAINT, A FOLLOW UP REPORT WILL BE SUBMITTED. AT THIS TIME, LIFESCAN CONSIDERS THIS MATTER CLOSED.

Additional Manufacturer Narrative · 1

LIFESCAN (LFS) HAS REQUESTED RETURN OF THE SUBJECT PRODUCT(S) FOR EVALUATION. IF THE PRODUCT(S) ARE RETURNED, LFS WILL EVALUATE IT/THEM AND INFORM FDA OF PRODUCT(S) THAT DO NOT PASS INSPECTION IN A SUPPLEMENTAL REPORT.

Description of Event or Problem · 1

ON (B)(6) 2014, THE LAY-USER/REPORTER CONTACTED LIFESCAN (LFS) USA ON BEHALF OF THE PATIENT, ALLEGING THAT THE ONETOUCH ULTRAMINI METER IS GIVING INACCURATE HIGH READINGS OF ¿132 AND 118 MG/DL¿ COMPARED TO ANOTHER METER READING OF ¿118 MG/DL.¿ THIS COMPLAINT WAS CLASSIFIED BASED ON THE CUSTOMER CARE ADVOCATE (CCA) DOCUMENTATION. ON (B)(6) 2014, AT 10 AM, THE PATIENT REPORTEDLY TOOK 0.12 UNIT OF VICTOZA AND MANAGED HIS DIABETES WITH INSULIN BASED ON THE ALLEGED READINGS OF ¿132 AND 118 MG/DL.¿ SUBSEQUENTLY, 1.5 HOURS LATER, THE PATIENT ALLEGEDLY DEVELOPED SYMPTOMS DESCRIBED AS ¿SHAKY, DIZZY, AND SWEATY.¿ DURING TROUBLESHOOTING, THE REPORTER CONFIRMED THE READINGS WERE TAKEN WITHIN 30 MINUTES OF EACH OTHER. THE UNIT OF MEASUREMENT WAS SET CORRECTLY. BASED ON STATISTICAL METHODOLOGY, THE CALCULATED DIFFERENCE OF THESE GLUCOSE RESULTS WERE WITHIN THE EXPECTED VALUE OF <= 30% AND/OR <= 30 MG/DL. THE LFS PRODUCTS WERE REPLACED AND REQUESTED BACK FOR INVESTIGATION. THIS COMPLAINT IS BEING REPORTED BECAUSE THE PATIENT CLAIMED SHE DEVELOPED SYMPTOMS SUGGESTIVE OF HYPOGLYCEMIA AFTER SHE TOOK INSULIN BASED ON THE ALLEGED INACCURATE HIGH METER READINGS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
345287 OT ULTRAMINI METER GLUCOSE MONITORING SYS/KIT NBW LIFESCAN EUROPE, A DIVISION OF CILAG GMBH INTL 3545750

Patients

Seq Age Sex Outcome Treatment
1 Life Threatening